We are live on ! Find out more
AVXL icon

Anavex Life Sciences
AVXL

65 hedge funds and large institutions have $32.6M invested in Anavex Life Sciences in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 14

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

5% more funds holding

Funds holding: 62 → 65 (+3)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.87% less ownership

Funds ownership: 23.8% → 22.93% (-0.87%)

21% less capital invested

Capital invested by funds: $41.5M → $32.6M (-$8.91M)

55% less call options, than puts

Call options by funds: $394K | Put options by funds: $869K

Holders
65
Holders Change
+3
Holders Change %
+4.84%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
21
Reduced
14
Closed
7
Calls
$394K
Puts
$869K
Net Calls
-$475K
Net Calls Change
+$3.58M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$305K
2
Bank of New York Mellon
Bank of New York Mellon
New York
+$263K
3
Deutsche Bank
Deutsche Bank
Germany
+$196K
4
Morgan Stanley
Morgan Stanley
New York
+$162K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$110K

Top Sellers

1
PWAM
Park West Asset Management
California
-$632K
2
VF
Virtu Financial
New York
-$102K
3
Russell Investments Group
Russell Investments Group
United Kingdom
-$79K
4
NFA
Nationwide Fund Advisors
Ohio
-$77K
5
TSS
Two Sigma Securities
New York
-$70.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
PWAM
1
Park West Asset Management
California
$8.73M -$632K -160,702 -6%
BlackRock
2
BlackRock
New York
$5.83M +$72.5K +18,433 +1%
Vanguard Group
3
Vanguard Group
Pennsylvania
$5.58M +$305K +77,560 +5%
KCM
4
Knoll Capital Management
Florida
$2.33M – – –
State Street
5
State Street
Massachusetts
$2.01M +$68.7K +17,459 +3%
Northern Trust
6
Northern Trust
Illinois
$1.36M -$16.5K -4,180 -1%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$1.02M +$30.5K +7,740 +2%
Susquehanna International Group
8
Susquehanna International Group
Pennsylvania
$851K +$110K +27,872 +12%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$573K +$263K +66,931 +60%
Morgan Stanley
10
Morgan Stanley
New York
$326K +$162K +41,289 +69%
Group One Trading
11
Group One Trading
Illinois
$302K +$67.1K +17,044 +22%
TCIM
12
TIAA CREF Investment Management
New York
$290K -$26.9K -6,823 -7%
Deutsche Bank
13
Deutsche Bank
Germany
$266K +$196K +49,904 +151%
Wells Fargo
14
Wells Fargo
California
$244K +$74.6K +18,944 +33%
SFG
15
SNS Financial Group
Minnesota
$225K – – –
TA
16
Teachers Advisors
New York
$218K – – –
California State Teachers Retirement System (CalSTRS)
17
California State Teachers Retirement System (CalSTRS)
California
$189K -$3K -763 -1%
T. Rowe Price Associates
18
T. Rowe Price Associates
Maryland
$178K +$4.27K +1,086 +2%
Charles Schwab
19
Charles Schwab
California
$165K – – –
EWM
20
Edge Wealth Management
New York
$162K – – –
CS
21
Credit Suisse
Switzerland
$153K -$58.3K -14,824 -24%
Millennium Management
22
Millennium Management
New York
$145K +$86.2K +21,895 +95%
Bank of America
23
Bank of America
North Carolina
$112K +$4.87K +1,238 +4%
RhumbLine Advisers
24
RhumbLine Advisers
Massachusetts
$108K -$29.1K -7,390 -18%
New York State Common Retirement Fund
25
New York State Common Retirement Fund
New York
$108K – – –
1
2 3

AVXL Hedge Fund Activity: Q4 2017 in Review

65 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q4 2017, worth a combined $32.6M — down 21% from $41.5M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new AVXL positions and 7 closed out — a net gain of 3 holders — while 21 added to existing stakes and 14 trimmed.

The largest buyer was Vanguard Group, adding an estimated $305K. The largest seller was Park West Asset Management, cutting an estimated $632K.

  • 65 institutional investors held Anavex Life Sciences (AVXL) as of Q4 2017, up from 62 in Q3 2017.
  • Funds reported $32.6M of Anavex Life Sciences stock for Q4 2017, down 21% quarter-over-quarter.
  • 10 funds opened new Anavex Life Sciences positions in Q4 2017 and 7 closed out, a net change of +3 holders.
  • The largest Anavex Life Sciences buyer in Q4 2017 was Vanguard Group, an estimated $305K added.
  • The largest Anavex Life Sciences seller in Q4 2017 was Park West Asset Management, an estimated $632K sold.

Based on aggregated 13F filings for Q4 2017.